SUMIT RATHOD

About

I have pursued my M. Pharm. (Pharmacology) degrees from R. T. M. Nagpur University, India, (2010) and currently pursuing my Ph.D. (Faculty of Medicine) at KBCNMU, Jalgaon University, India. I'm a member of professional bodies like the Indian Pharmacological Society. I have completed 05 industrial projects. I have guided 08 PG students in their research projects. I have authored/co-authored more than 23 publications in several reputed journals and have presented my studies at various conferences. My research interests mainly focus on neurodegenerative diseases and drug dependence.

Employment

• SVKM's Institute of Pharmacy Assistant Professor
  2019 - Present
• Apollo Hospitals Sr. Executive Training and Development
  2017 - 2019
• Rajarshi Shahu College of Pharmacy Buldana Assistant Professor
  2014 - 2017
• Institute of Pharmaceutical Education and Research Assistant Professor
  2011 - 2014
• Shri. Suresh Dada Jain Institute of Pharmaceutical Education and Research, Jamner Assistant Professor
  2010 - 2011

Education

• North Maharashtra University PhD
  2020 - Present
• Agnihotri College of Pharmacy M. Pharm
  2008 - 2010
• Anuradha College of Pharmacy B. Pharm
  2003 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Hentriacontane alleviates streptozotocin-induced Alzheimer's disease-like conditions in rats: In silico and in vivo investigations revealed the unifying principles
  Computers in Biology and Medicine 2026 DOI: 10.1016/j.compbiomed.2026.111513
  +Save
• Intracerebroventricular streptozotocin-induced animal model of Alzheimer’s disease: revealing dose optimization, administration regimen, and molecular pathways
  Laboratory Animal Research 2026 DOI: 10.1186/s42826-026-00278-6
  +Save
• β‐Caryophyllene Ameliorates STZ‐Induced Alzheimer's Disease‐Like Conditions in Rats via Modulation of Brain‐Derived Neurotrophic Factor, Synaptic Plasticity, and Neuroinflammation
  European Journal of Neuroscience 2025 DOI: 10.1111/ejn.70317
  +Save
• In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway
  Current Protein & Peptide Science 2025 DOI: 10.2174/0113892037383576250909075917
  +Save
• Thiopentone in Combination with Xylazine: An Experimental Investigation for Induction of Surgical Anesthesia and Safe Recovery in Experimental Rats
  Current Drug Research Reviews 2025 DOI: 10.2174/0125899775370000250728050535
  +Save
• Recent Advances in Molecular Docking Techniques: Transforming Perspectives in Distinct Drug Targeting and Drug Discovery Approaches
  Medicinal Chemistry 2025 DOI: 10.2174/0115734064384472250716144736
  +Save
• β-Caryophyllene (CB2 agonist) mitigates rotenone-induced neurotoxicity and apoptosis in SH-SY5Y neuroblastoma cells via modulation of GSK-3β/NRF2/HO-1 axis
  Naunyn-Schmiedeberg's Archives of Pharmacology 2025 DOI: 10.1007/s00210-025-04281-x
  +Save
• Novel Strategies of Antioxidants In Chronic Inflammatory Diseases
  Antioxidants as Nutraceuticals 2024 DOI: 10.1201/9781003534877-8
  +Save
• CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms25031683
  +Save
• Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer’s Disease
  Current Drug Research Reviews 2023 DOI: 10.2174/2589977515666230502104021
  +Save